# SERS Sensor Based on CHA Reaction for EGFR Mutation Typing in Advanced Lung Cancer

> **NCT06772376** · — · NOT_YET_RECRUITING · sponsor: **Fuzhou General Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Lung Cancer in Normal and Malignant Tumors

## Interventions

- **DIAGNOSTIC_TEST:** SERS sensor based on CHA reaction

## Key facts

- **NCT ID:** NCT06772376
- **Lead sponsor:** Fuzhou General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06772376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06772376, "SERS Sensor Based on CHA Reaction for EGFR Mutation Typing in Advanced Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06772376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*